Cases 11 - 20 of 272
BRISTOL-MYERS SQUIBB COMPANY v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 3:2023cv21098
Plaintiff:
BRISTOL-MYERS SQUIBB COMPANY
Defendant:
ZYDUS PHARMACEUTICALS (USA) INC. and ZYDUS LIFESCIENCES LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
BRISTOL-MYERS SQUIBB COMPANY v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 1:2023cv21098
Plaintiff:
BRISTOL-MYERS SQUIBB COMPANY
Defendant:
ZYDUS PHARMACEUTICALS (USA) INC. and ZYDUS LIFESCIENCES LIMITED
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Par Pharmaceutical, Inc. et al v. Zydus Pharmaceuticals (USA) Inc. et al
as 1:2023cv00866
Plaintiff:
Par Pharmaceutical, Inc. and Epic Par Innovation Company, LLC
Defendant:
Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Ltd.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AZURITY PHARMACEUTICALS, INC. et al v. ZYDUS WORLDWIDE DMCC et al
as 3:2023cv04152
Plaintiff:
AZURITY PHARMACEUTICALS, INC., ARBOR PHARMACEUTICALS, LLC and TAKEDA PHARMACEUTICAL COMPANY LIMITED
Defendant:
ZYDUS WORLDWIDE DMCC, ZYDUS PHARMACEUTICALS (USA) INC. and ZYDUS LIFESCIENCES LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Azurity Pharmaceuticals, Inc. et al v. Zydus Worldwide DMCC et al
as 1:2023cv00833
Plaintiff:
Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC and Takeda Pharmaceutical Company Limited
Defendant:
Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Astellas Pharma Inc. et al v. Lupin Ltd. et al
as 1:2023cv00819
Plaintiff:
Astellas Pharma Inc., Astellas Ireland Co., Ltd. and Astellas Pharma Global Development, Inc.
Defendant:
Lupin Ltd., Lupin Pharmaceuticals, Inc., Sandoz Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Biogen Inc. et al v. Zydus Worldwide DMCC et al
as 1:2023cv00732
Plaintiff:
Biogen Inc., Biogen Swiss Manufacturing GmbH and Alkermes Pharma Ireland Limited
Defendant:
Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
ARAGON PHARMACEUTICALS, INC. et al v. ZYDUS WORLDWIDE DMCC et al
as 2:2023cv01685
Plaintiff:
ARAGON PHARMACEUTICALS, INC., JANSSEN BIOTECH, INC. and THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
Defendant:
ZYDUS WORLDWIDE DMCC, ZYDUS PHARMACEUTICALS (USA) INC. and ZYDUS LIFESCIENCES LIMITED
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
Keryx Biopharmaceuticals, Inc. et al v. Zydus Worldwide DMCC et al
as 1:2023cv00331
Plaintiff:
Keryx Biopharmaceuticals, Inc. and Panion & BF Biotech, Inc.
Defendant:
Zydus Worldwide DMCC, Zydus Pharmaceuticals (USA) Inc. and Zydus Lifesciences Limited
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
NEUROCRINE BIOSCIENCES, INC. v. ZYDUS PHARMACEUTICALS (USA) INC. et al
as 3:2023cv01369
Plaintiff:
NEUROCRINE BIOSCIENCES, INC.
Defendant:
ZYDUS PHARMACEUTICALS (USA) INC., ZYDUS WORLDWIDE DMCC, ZYDUS HEALTHCARE (USA) LLC and others
Cause Of Action: 35 U.S.C. § 145 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
